ALEXANDRA CARRICO: Open Payments
NPI 1023881661 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 27 payments from 11 companies in 2025. Trend: 2023 $44 · 2024 $1,204 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $155 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| PFIZER INC. | 3 | $47 |
| Abbott Laboratories | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
| Exact Sciences Corporation | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $20 |
Products named: Kerendia, FREESTYLE LIBRE 3, JARDIANCE, PREVNAR 20, FARXIGA, Dexcom G6 Transmitter, INTELLIS ADAPTIVESTIM, MOUNJARO.
Industry payments across IN — which companies pay providers there.
